Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Langlais

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|August 10, 2021
Structural and molecular bases to IRE1 activity modulationTimothy Langlais, Diana Pelizzari-Raymundo, Sayyed Jalil Mahdizadeh, et al.
Iscience|May 22, 2023
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatmentDiana Pelizzari-Raymundo, Dimitrios Doultsinos, Raphael Pineau, et al.
Molecules (Basel, Switzerland)|November 16, 2018
From Quinoxaline, Pyrido[2,3-<i>b</i>]pyrazine and Pyrido[3,4-<i>b</i>]pyrazine to Pyrazino-Fused Carbazoles and CarbolinesFrédéric Lassagne, Timothy Langlais, Elsa Caytan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|August 10, 2021
Structural and molecular bases to IRE1 activity modulationTimothy Langlais, Diana Pelizzari-Raymundo, Sayyed Jalil Mahdizadeh, et al.
Iscience|May 22, 2023
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatmentDiana Pelizzari-Raymundo, Dimitrios Doultsinos, Raphael Pineau, et al.
Molecules (Basel, Switzerland)|November 16, 2018
From Quinoxaline, Pyrido[2,3-<i>b</i>]pyrazine and Pyrido[3,4-<i>b</i>]pyrazine to Pyrazino-Fused Carbazoles and CarbolinesFrédéric Lassagne, Timothy Langlais, Elsa Caytan, et al.
Pageof 1